scholarly journals Immunohistochemical Examinations of Sex Hormone Receptors in Benign Vocal Fold Lesions

2009 ◽  
Vol 61 (5) ◽  
pp. 259-262 ◽  
Author(s):  
Eleonore Cohen ◽  
Andrea Kolbus ◽  
Michael van Trotsenburg ◽  
Margarethe Rudas ◽  
Reinhard Horvat ◽  
...  
2011 ◽  
Vol 63 (2) ◽  
pp. 77-82 ◽  
Author(s):  
Andrea Nacci ◽  
Bruno Fattori ◽  
Fabio Basolo ◽  
Maria E. Filice ◽  
Katia De Jeso ◽  
...  

2007 ◽  
Vol 21 (4) ◽  
pp. 502-507 ◽  
Author(s):  
Berit Schneider ◽  
Eleonore Cohen ◽  
Josefine Stani ◽  
Andrea Kolbus ◽  
Margarethe Rudas ◽  
...  

2009 ◽  
Vol 19 (3) ◽  
pp. 105-112 ◽  
Author(s):  
Geralyn Harvey Woodnorth ◽  
Roger C. Nuss

Abstract Many children with dysphonia present with benign vocal fold lesions, including bilateral vocal fold nodules, cysts, vocal fold varices, and scarring. Evaluation and treatment of these children are best undertaken in a thoughtful and coordinated manner involving both the speech-language pathologist and the otolaryngologist. The goals of this article are (a) to describe the team evaluation process based on a “whole system” approach; (b) to discuss etiological factors and diagnosis; and (c) to review current medical, behavioral, and surgical treatments for children with different types of dysphonia.


2021 ◽  
Author(s):  
Mayu Hirosaki ◽  
Takeharu Kanazawa ◽  
Daigo Komazawa ◽  
Ujimoto Konomi ◽  
Yu Sakaguchi ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 1169
Author(s):  
Hiroki Ide ◽  
Hiroshi Miyamoto

There have been critical problems in the non-surgical treatment for bladder cancer, especially residence to intravesical pharmacotherapy, including BCG immunotherapy, cisplatin-based chemotherapy, and radiotherapy. Recent preclinical and clinical evidence has suggested a vital role of sex steroid hormone-mediated signaling in the progression of urothelial cancer. Moreover, activation of the androgen receptor and estrogen receptor pathways has been implicated in modulating sensitivity to conventional non-surgical therapy for bladder cancer. This may indicate the possibility of anti-androgenic and anti-estrogenic drugs, apart from their direct anti-tumor activity, to function as sensitizers of such conventional treatment. This article summarizes available data suggesting the involvement of sex hormone receptors, such as androgen receptor, estrogen receptor-α, and estrogen receptor-β, in the progression of urothelial cancer, focusing on their modulation for the efficacy of conventional therapy, and discusses their potential of overcoming therapeutic resistance.


Author(s):  
Yetkin Zeki Yılmaz ◽  
Müge Uğurlar ◽  
Begüm Bahar Yılmaz ◽  
Züleyha Dilek Gülmez ◽  
Hasan Ahmet Özdoğan ◽  
...  

2017 ◽  
Vol 31 (4) ◽  
pp. 476-482 ◽  
Author(s):  
Tolga Kirgezen ◽  
Ahmet Volkan Sunter ◽  
Ozgur Yigit ◽  
Gulben Erdem Huq

2014 ◽  
Vol 125 (1) ◽  
pp. 191-196 ◽  
Author(s):  
Alisa Zhukhovitskaya ◽  
Danielle Battaglia ◽  
Sid M. Khosla ◽  
Thomas Murry ◽  
Lucian Sulica

Sign in / Sign up

Export Citation Format

Share Document